Beyond Morphology: Understanding Tumor Budding, Lymphovascular Invasion, and Perineural Invasion in Colorectal Cancer.

Abstract

The American Joint Committee on Cancer (AJCC) TNM staging system, grounded in morphologic assessment of tumor invasion depth, remains the cornerstone of surgical decision-making and prognostication for colorectal cancer (CRC). However, marked prognostic heterogeneity among patients at identical T stages represents a longstanding clinical challenge that cannot be fully accounted for by conventional morphologic evaluation alone. Epithelial-mesenchymal transition (EMT), the core biological process driving tumor cell invasion and metastasis, may provide a unifying biologic framework to interpret this stage-specific variability. From a surgical perspective, this review summarizes the established clinical and prognostic significance of routinely reported pathologic features-tumor budding, lymphovascular invasion (LVI), and perineural invasion (PNI)-and explores how EMT biology may explain their underlying biological basis. We outline how EMT activation may underpin the aggressive behavior associated with these histologic findings, and how it may account for prognostic heterogeneity in stage II disease. Finally, we outline emerging investigational applications of EMT biology, including biomarker testing, biologically informed margin assessment, and integrated staging systems, and discuss their potential future role in surgical practice.